1. Home
  2. BIVI vs EDTK Comparison

BIVI vs EDTK Comparison

Compare BIVI & EDTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • EDTK
  • Stock Information
  • Founded
  • BIVI 2013
  • EDTK 2013
  • Country
  • BIVI United States
  • EDTK China
  • Employees
  • BIVI N/A
  • EDTK N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • EDTK Other Consumer Services
  • Sector
  • BIVI Health Care
  • EDTK Real Estate
  • Exchange
  • BIVI Nasdaq
  • EDTK Nasdaq
  • Market Cap
  • BIVI 15.0M
  • EDTK 15.9M
  • IPO Year
  • BIVI N/A
  • EDTK 2020
  • Fundamental
  • Price
  • BIVI $1.60
  • EDTK $1.06
  • Analyst Decision
  • BIVI
  • EDTK
  • Analyst Count
  • BIVI 0
  • EDTK 0
  • Target Price
  • BIVI N/A
  • EDTK N/A
  • AVG Volume (30 Days)
  • BIVI 434.0K
  • EDTK 7.3K
  • Earning Date
  • BIVI 08-15-2025
  • EDTK 08-08-2025
  • Dividend Yield
  • BIVI N/A
  • EDTK N/A
  • EPS Growth
  • BIVI N/A
  • EDTK N/A
  • EPS
  • BIVI N/A
  • EDTK N/A
  • Revenue
  • BIVI N/A
  • EDTK $893,690.00
  • Revenue This Year
  • BIVI N/A
  • EDTK N/A
  • Revenue Next Year
  • BIVI N/A
  • EDTK N/A
  • P/E Ratio
  • BIVI N/A
  • EDTK N/A
  • Revenue Growth
  • BIVI N/A
  • EDTK N/A
  • 52 Week Low
  • BIVI $1.46
  • EDTK $0.80
  • 52 Week High
  • BIVI $75.00
  • EDTK $1.20
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 21.13
  • EDTK 57.58
  • Support Level
  • BIVI $1.46
  • EDTK $1.00
  • Resistance Level
  • BIVI $1.84
  • EDTK $1.17
  • Average True Range (ATR)
  • BIVI 0.40
  • EDTK 0.06
  • MACD
  • BIVI 0.02
  • EDTK 0.01
  • Stochastic Oscillator
  • BIVI 3.08
  • EDTK 62.17

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About EDTK Skillful Craftsman Education Technology Limited

Skillful Craftsman Education Technology Ltd provides online education and technology services in China. The services comprises of two aspects - Online vocational training and Virtual simulation experimental training. It covers a wide range of subjects, including mechanics, electronics, auto repair and construction. Majority of its revenues are generated from the People's Republic of China.

Share on Social Networks: